Yokohama, Japan

Norio Ezaki


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Yokohama, JA (1977)
  • Yokohama, JP (1979 - 1985)

Company Filing History:


Years Active: 1977-1985

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Norio Ezaki: Innovator in Antibiotic Development

Introduction

Norio Ezaki is a prominent inventor based in Yokohama, Japan, known for his significant contributions to the field of antibiotics. With a total of 10 patents to his name, he has made remarkable advancements in the development of antibiotic substances.

Latest Patents

One of his latest patents is for an antibiotic designated as pyrrolomycin E. This antibiotic is obtained by cultivating a pyrrolomycin E-producing strain belonging to the genus Streptomyces, specifically Streptomyces sp. SF-2080. The process involves cultivating this strain in a nutrient medium and recovering pyrrolomycin E from the culture, which also contains other antibiotic substances such as pyrrolomycin A, B, C, and D. Another notable patent is for the antibiotic SF-2103A, which describes both the substance and the process for its production. This process includes cultivating an antibiotic SF-2103A substance-producing strain in a nutrient medium and recovering the desired substance from the culture broth.

Career Highlights

Norio Ezaki is associated with Meiji Seika Kaisha, Ltd., where he has been instrumental in advancing antibiotic research and development. His work has significantly impacted the pharmaceutical industry, particularly in the area of antibiotic production.

Collaborations

Throughout his career, Norio has collaborated with notable colleagues such as Tomizo Niwa and Yujiro Yamada. These collaborations have further enhanced his research and contributed to the success of his inventions.

Conclusion

Norio Ezaki's innovative work in antibiotic development has led to significant advancements in the field. His contributions continue to influence the pharmaceutical industry and improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…